Session I

Hodgkin lymphoma

Signaling pathways and immune evasion mechanisms in HL
S.A. Pileri
Primary refractory/early relapse
C.H. Moskowitz
CAR-T cells
J. Briones
Session II

PTCL/CTCL

New targeted agents in PTCL
E. Marchi
Lecture

How I treat WM
S.P. Treon
Session III

DLBCL

Incorporating novel agents in frontline treatment
G. Nowakowski
The new algorithm for second and third lines
J.R. Westin
The role of bispecifics
J.S. Abramson
Session IV

Follicular lymphoma

What is the new order?
B.D. Cheson
Bispecifics antibodies or CAR-T cells
C.A. Jacobson
Novel agents/combinations
C.R. Flowers
Session V

CAR-T cells

Novel agents/tandem CARs
S.J. Schuster
In secondary CNS lymphoma
J.S. Abramson
Cytopenia and infections
M. Aljurf
DEBATE: Pro CAR-T cells
J.S. Abramson
DEBATE: Pro CAR-T cells
Pro Bispecifics
Session VI

Mantle cell lymphoma

Bispecifics
T. Phillips
Privacy Policy | Cookie Policy